LEADER 01744nam  2200553Ia 450 
001 9910778776703321
005 20230421033219.0
010   $a0-309-17444-9
010   $a1-280-18720-4
010   $a9786610187201
010   $a0-309-59145-7
010   $a0-585-15632-8
035   $a(CKB)110986584752202
035   $a(OCoLC)43477344
035   $a(CaPaEBR)ebrary10055149
035   $a(SSID)ssj0000166900
035   $a(PQKBManifestationID)11163687
035   $a(PQKBTitleCode)TC0000166900
035   $a(PQKBWorkID)10168904
035   $a(PQKB)10887604
035   $a(Au-PeEL)EBL3376155
035   $a(CaPaEBR)ebr10055149
035   $a(OCoLC)923260976
035   $a(MiAaPQ)EBC3376155
035   $a(EXLCZ)99110986584752202
100   $a19980107d1997      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aHalcion$b[electronic resource] $ean independent assessment of safety and efficacy data /$fCommittee on Halcion: An Assessment of Data Adequacy and Confidence, Division of Health Sciences Policy, Division of Neuroscience and Behavioral Health, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$d1997
215   $a1 online resource (176 p.) 
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-05976-3 
320   $aIncludes bibliographical references.
606   $aTriazolam
606   $aTranquilizing drugs
615  0$aTriazolam.
615  0$aTranquilizing drugs.
676   $a615/.782
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778776703321
996   $aHalcion$93772494
997   $aUNINA